17 alpha-Hydroxyprogesterone Caproate [hydroxyprogesteron kaproát]
- Terms
-
17 alfa-hydroxyprogesteron kaproát
hydroxyprogesteron hexanoát
Neolutin forte
-
17 alpha-Oxyprogesterone Capronate
17-alpha-Hydroxy-Progesterone Caproate
17-Hydroxyprogesterone Capronate
Delalutin
Hydroxyprogesterone Caproate
Hydroxyprogesterone Hexanoate
Makena
Neolutin
Oxyprogesterone Caproate
Prolutin Depot
Proluton Depot
Hydroxyprogesterone derivative that acts as a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS.
- DUI
- D000077713 MeSH Browser
- CUI
- M0074009
- RN
- 276F2O42F5
- CAS
- Hexanoic acid, 3,20-dioxopregn-4-en-17-yl ester
- History note
- 2019 (1979)
- Public note
- 2019;see 17-ALPHA-HYDROXY-PROGESTERONE CAPROATE 2003-2018; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE was indexed under HYDROXYPROGESTERONES 1979-2018
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UR
- urine 0